These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 14013017)

  • 1. [Paraproteinosis in myeloma].
    ANDREEVA NE
    Arkh Patol; 1962; 24(12)():3-14. PubMed ID: 14013017
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic hepatopathies with paraproteinosis and paraproteinosis with hepatic repercussions].
    TEODORESCU P; SASARMAN M; GANCEVICI A; IONASESCU R
    Med Interna (Bucur); 1962 Dec; 14():1443-53. PubMed ID: 13980597
    [No Abstract]   [Full Text] [Related]  

  • 3. [RUDIMENTARY PARAPROTEINEMIA, AN EARLY FORM OF MULTIPLE MYELOMA?].
    MAERKI HH; WUHRMANN F
    Schweiz Med Wochenschr; 1963 Sep; 93():1381-7. PubMed ID: 14055093
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasmocytic myeloma with paraprotein of alpha-2 mobility. Clinical and biological considerations].
    VINCENT G; PAGET M; GIARD P; VINCENT G; DUHAMEL M; LEURIDAN B
    J Sci Med Lille; 1963 Apr; 81():181-6. PubMed ID: 13997339
    [No Abstract]   [Full Text] [Related]  

  • 5. [Myeloma and associated diseases in Japan].
    Takatsuki K; Kano T
    Naika; 1966 Feb; 17(2):331-6. PubMed ID: 5960014
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hematologic and morphological findings in rudimentary paraproteinemia].
    Märki HH; Siegenthaler R
    Schweiz Med Wochenschr; 1965 Oct; 95(43):1430-1. PubMed ID: 5880925
    [No Abstract]   [Full Text] [Related]  

  • 7. [A case of post-hepatitis liver sclerosis with pseudomyelomatous hyperproteinemia].
    COPPO M; BARATTA PF
    Rev Int Hepatol; 1962; 12():783-802. PubMed ID: 14022919
    [No Abstract]   [Full Text] [Related]  

  • 8. [Some observations on 9 patients with paraproteinosis].
    ALTHAMMER R; SCHMIDT G
    Z Gesamte Inn Med; 1962 Nov; 17():945-50. PubMed ID: 14012319
    [No Abstract]   [Full Text] [Related]  

  • 9. [Serum gel reaction as the screening test of paraproteinemia)].
    Ito C; Kano A; Ishitoya Y; Onodera K
    Rinsho Byori; 1966 Nov; 14(11):765-8. PubMed ID: 6009732
    [No Abstract]   [Full Text] [Related]  

  • 10. [ELECTRON MICROSCOPIC STUDY OF INTRANUCLEAR INCLUSIONS IN AN ATYPICAL MEDULLARY PLASMOCYTOSIS WITH DYSGLOBULINEMIA].
    GADRAT J; MONNIER J; IZARD J; BOURSE R; DE BOISSEZON JF
    Bull Assoc Fr Etud Cancer; 1963; 50():251-61. PubMed ID: 14073501
    [No Abstract]   [Full Text] [Related]  

  • 11. [Paraproteinosis induced by cadmium].
    BARNI M; GRAEV M
    Med Lav; 1962 Nov; 53():683-95. PubMed ID: 13969410
    [No Abstract]   [Full Text] [Related]  

  • 12. Sjögren's syndrome associated with multiple myeloma.
    Tazi I; Rachid M; Benchekroun S
    Singapore Med J; 2008 Aug; 49(8):e215-6. PubMed ID: 18756337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications of multiple myeloma.
    Bladé J; Rosiñol L
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1231-46, xi. PubMed ID: 17996596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma cell disorders in HIV-infected patients: from benign gammopathy to multiple myeloma.
    Dezube BJ; Aboulafia DM; Pantanowitz L
    AIDS Read; 2004 Jul; 14(7):372-4, 377-9. PubMed ID: 15282866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF.
    Callera F; Cavenaghi L; de Melo CM
    Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bioluminescence imaging based in vivo model for preclinical testing of novel cellular immunotherapy strategies to improve the graft-versus-myeloma effect.
    Rozemuller H; van der Spek E; Bogers-Boer LH; Zwart MC; Verweij V; Emmelot M; Groen RW; Spaapen R; Bloem AC; Lokhorst HM; Mutis T; Martens AC
    Haematologica; 2008 Jul; 93(7):1049-57. PubMed ID: 18492693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FTY720 induces apoptosis in multiple myeloma cells and overcomes drug resistance.
    Yasui H; Hideshima T; Raje N; Roccaro AM; Shiraishi N; Kumar S; Hamasaki M; Ishitsuka K; Tai YT; Podar K; Catley L; Mitsiades CS; Richardson PG; Albert R; Brinkmann V; Chauhan D; Anderson KC
    Cancer Res; 2005 Aug; 65(16):7478-84. PubMed ID: 16103102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis.
    Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM
    Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment with a proteasome inhibitor, bortezomib, for thalidomide-resistant multiple myeloma].
    Takatoku M; Noborio-Hatano K; Takahashi S; Kikuchi S; Mori M; Muroi K; Komatsu N; Ozawa K
    Rinsho Ketsueki; 2004 Feb; 45(2):144-8. PubMed ID: 15045823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.